Use of Slow-Release Injectable Moxidectin for Treatment of Dirofilaria immitis Infection During Pregnancy
Canine heartworm disease is a life-threatening disease caused by Dirofilaria immitis and is prevalent in Brazil. The standard drug for its treatment, melarsomine dihydrochloride, is a fast-killing organic arsenical chemotherapeutic agent not approved in Brazil. Therefore, an alternative strategy, su...
Main Authors: | Bruno Alberigi, Celeste da Silva Freitas de Souza, Julio Israel Fernandes, Alexandre Merlo, Norma Labarthe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fvets.2019.00440/full |
Similar Items
-
Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs
by: Tom L. McTier, et al.
Published: (2017-11-01) -
Chemoprophylaxis of Dirofilaria immitis (Leidy 1856) infection at a high challenge environment
by: Norma Vollmer Labarthe, et al.
Published: (2015-10-01) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
by: Tom L. McTier, et al.
Published: (2019-07-01) -
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
by: Tom L. McTier, et al.
Published: (2019-09-01) -
Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis
by: Elizabeth M. Martin, et al.
Published: (2024-04-01)